안국약품(주)

Obtained the integrated certificate of ISO 37301 and
ISO 37001 for the first time in Korea
2021 Received a citation from Korea Human Resource Development Institute for Health & Welfare

Held Auh Jun-seon scholarship ceremony at Chung-Ang University

Signed an MOU with Digital Treatment Research Center of Samsung Medical Center
Selected as the Project for Development of Dementia Medicine by the Ministry of Oceans and Fisheries

Opened ‘AWONDER,’ an official brand shopping mall

Selected Hong Jin-gyeong for the advertisement of Tobicom
Launched “Tobicom,” eye health functional food

Introduced the in-house professional recruiting interviewer qualification system for the first time in the industry

Received the Filial Act Prize from the Yeongdeungpo-gu Office in 2021

Launched Medifer, ‘Lutein Eye Cream’

Launched ‘Rifozet,’ a combination drug for dyslipidemia

Held the web symposium for ‘Circaton PR Tab.’

Concluded a sales contract for ‘KardiaMobile’ of AliveCor
Introduced the AI Chatbot service

Released the ‘Tobicome Series’ in Chinese online shopping mall ‘Tmall’

Released Medifer ‘the second-generation Lutein ampoule’

Held a ceremony to declare the new vision

Released ‘Forlax 4g,’ a pediatric constipation drug

Held the award ceremony for new writers of 2020 Ahn-gook Gallery

Signed a partnership agreement for ‘Tobicom S’ with Kyung Nam Pharm

Donated ‘Tobicom Gold’ for COVID-19 relief

Provided training for 2020 ISO 37001 and CP (For all employees)

Donated to the ChildFund Korea

Received recertification as Excellent culture and art sponsor
by the Ministry of Culture, Sports and Tourism

Passed the qualification review for the anti-bribery management system (ISO 37001)

Signed a joint research partnership with Daegu Gyeongbuk Institute of Science and Technology for development of new anticancer drugs

Celebrated our 60th anniversary

Signed a new drug candidate transfer contract with Rapigen Inc.

Signed a partnership agreement with Inje University for technology transfer and joint research

Launched a home shopping channel, ‘Medifer Lutein Force Ampoule’
Obtained the anti-bribery management system ‘ISO 37001’ certification

Chair Auh Jun-seon established a scholarship fund of 1.2 billion won
Released Rupafin Tab., an antihistamine drug

Selected as National Project for Growth Hormone Deficiency Drug

Signed an exclusive distribution contract with HBN of Vietnam for Synatura syrup

Aired Tobicom Gold’ TV commercial

Signed a joint development agreement with Kangstem Biotech for cell-based antipsoriatic drug

Signed an exclusive distribution contract with South Africa and other 8 countries for Synatura syrup

Signed an exclusive distribution contract with Kuwait for Synatura syrup

Received recertification as Innovative Pharmaceutical Company by the Ministry of Health & Welfare

Signed an MOU with the Korea Institute of Oriental Medicine for development of nature-derived drug for diabetic retinopathy

Signed an exclusive disribition contract with Iran for sales of Synatura syrup

Signed a joint distribution contract with Sandoz Korea for COPD drug, ‘AirFluSal Forspiro’

Signed a copromotion contract with Baxter for ’Cernevit Inj.’

Signed a copromotion contract with Pfizer Korea for ’Viagra Tab.’

Signed a sales partnership with Kwang Dong Pharmaceutical for ’Tobicom Soft Cap.’

Ceragem Medisys ‘diabetes diagnostic device was approved by the CFDA of China

Ahn-gook’s central R&D Center was relocated to Guro Digital Complex

Released ‘Levosartan Tab.,’ Korea’s first combination drug of CCB and ARB

Signed a licensing contract with the U.S.-based GravityBiofor for ‘Synatura syrup’

Signed an exclusive distribution contract with EffRx of Switzerland for sales of ‘Binosto Tab., the world’s first effervescent tablet for osteoporosis
Signed an exclusive licensing contract with Hebang Group of China for sales of ‘Anycough Cap.’

Signed an exclusive contract with Proteomika of Spain for ‘Antibody Medicine Monitoring Kit’

Released ‘Retopra Tab.’ an isomer IMD

Signed an exclusive distribution contract with Takeda Korea for ‘Zycomb®,’ a nasal spray

Signed the project agreement with the Ministry of Knowledge Economy of Korea for development of mRNA-miRNA complex diagnostic system for prognostic prediction and treatment guide of gastric cancer and mouth cancer’

Certified as Innovative Pharmaceutical Company by the Ministry of Health & Welfare of Korea

Introduced ‘Rupafin,’ a new antihistamine drug, and signed an export agreement for ‘Synatura syrup’

Signed an export agreement for ‘Synatura syrup,’ a new nature-derived drug with China and Vietnam

Selected as National Project for ’Early detection of ovarian cancer using urine,’ by the Ministry of Knowledge Economy of Korea
Signed a copromotion contract for ‘Harnal®D and Vesicare’ with Astellas Pharma Korea

Launched ‘Synatura syrup,’ Korea No. 5 new nature-derived drug
Held ‘Ahn-gook half century’ exhibition celebrating our 52nd anniversary

Signed a joint research agreement of cancer early detection technology with Hallym University

Held a ceremony celebrating the completion of cGMP factory

Signed a licensing contract for ‘Anycough’ with ‘PepTcell’ of UK and its subsidiary ‘Biocopea’

Submitted patent application for a new substance, developed in partnership with EQUISnZAROO

Acquired ‘Biomedlab,’ a biotech venture

Won the patent lawsuit for Levotension
Celebrated our 50th anniversary

Established a subsidiary AG Green

Held the groundbreaking ceremony for cGMP-certified facilities

CP manager received a Citation from Fair Trade Commission of Korea

Selected as SME Promising Project in 2008

Received the Grand prize in the category of technology innovation in the 8th Korea Commodity Award

Signed a license contract for ‘Shiulinjia,’ a new hepatic protector, with Tasly Group of China
Signed an investment and strategic alliance contract with DNA Link

Signed a sales contract for ‘HPV DNA CHIP’ with ‘Biomedlab’

Selected as Excellent Human Resources Development Company in 2007

Signed a distribution contract for the world’s first needle-free injection system, “INJEX” with INJEX KOREA

Chair Auh Jun-seon received “2007 Korea Global Businessman Award

Opened the Central R&D Center in Gyeonggi Bio Center

Chair Auh Jun-seon was appointed the 21st director in Korea Pharmaceutical and Bio-Pharma Manufacturers Association

Chair Auh Jun-seon earned “Honorary Ph D of economics” from Chung-Ang University

Chair Auh Jun-seon was selected as an awardee of Da Vinci Diamond of International Biographical Centre Cambridge, England

Released Levotension (hypertension drug)

Signed a contract for moving into “Osong Biovalley” in Cheongju

Chair Auh Jun-seon was listed in the ‘Contemporary Who’s Who’ in 2005

Ahn-gook Family House was completed (Nogok-ri, Anseong-si, Gyeonggi-do)

CEO & President Auh Jin received ‘the CEO Award’ (The Korean Academic Association of Business Administration)

Declared three core values and behavioral principles (held Ahn-gook Festival)

Established a synthesis factory within the Hyangnam Plant

Selected as ‘2003 First-Half New Management-Labor Culture Company’ by the Ministry of Employment and Labor of Korea

Achieved sales of KRW 45.4 billion and ordinary profits of KRW 10.8 billion
Reached the Best Growth Record with 44.5% growth from the previous year

Received ‘2002 Talent Management Award, Best Company’ prize from the Korea Management Association

Executed stock split by reducing price from KRW 5,000 to KRW 500 per share in the general meeting of shareholders

Started the Antismoking campaign with a goal of reaching KRW 50 bil. in 2002

Achieved sales of KRW 31.4 bn. and ordinary profit of KRW 6.2 bil.

Chairman Auh Jun-seon received the Moran medal in celebration of the World Health Day

Achieved sales of KRW 24.4 billion and ordinary profit of KRW 4.2 billion

Released ‘HemoGold Tab.,’ anemia drug, for the first time in Korea

Listed on the KOSDAQ, and Ahn-gook shares started being traded on KOSDAQ
Increased capital to KRW 5,750,000,000 through public offering

Constructed a new information management system

CEO & Chair Auh Jun-seon was inaugurated
CEO & President Park Seong-joon was inaugurated

Founded [Employee’s stock ownership association.] (95 members, 54,000 shares of stock)

Completed the construction of KGMP factory (within the Hyangnam Pharmaceutical Industries Complex)

Started the construction of KGMP factory (within the Hyangnam Pharmaceutical Industries Complex)

Received the Industrial Service Medal (Day of Businessmen)

Awarded USD 1 million Export Tower (Day of Export)

Exported medicines ‘Obason, Aidaring, Tusscochin, etc.’ to Brunei Serigia

Relocated headquarters to 993-3, Daerim-2 dong, Yeongdeungpo-gu and expanded and moved factory

CEO Auh Jun-seon was inaugurated

Released the Korea’s first antibiotic ‘Feminine eye drop’

Changed the status of entity to Ahn-gook Pharm corporation on the anniversary day

Founded Ahn-gook with a capital of KRW 15,000,000 in 108, Hangang-ro 2-ga, Yongsan-gu